Medical Care

Global Human Microbiome Sequencing Services Market Outlook, In‑Depth Analysis & Forecast to 2031

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Human Microbiome Sequencing Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Illumina
IGATech
Genetic Analysis
BaseClear
Microba Life Sciences
Viome
Goodgut
Origin Sciences
Ixcela
ProDigest
Enterome
The BioCollective
ZOE
Qiagen
Segment by Type
16S rRNA Sequencing
Shot Gun Metagenomics
Metatranscriptomics
Others
Segment by Application
Hospitals
Research Institutes
Pharmaceutical Companies
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Human Microbiome Sequencing Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Human Microbiome Sequencing Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Human Microbiome Sequencing Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 16S rRNA Sequencing
1.2.3 Shot Gun Metagenomics
1.2.4 Metatranscriptomics
1.2.5 Others
1.3 Market Segmentation by Application
1.3.1 Global Human Microbiome Sequencing Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Research Institutes
1.3.4 Pharmaceutical Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Microbiome Sequencing Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Human Microbiome Sequencing Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Human Microbiome Sequencing Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Human Microbiome Sequencing Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 16S rRNA Sequencing Market Size by Players
3.3.2 Shot Gun Metagenomics Market Size by Players
3.3.3 Metatranscriptomics Market Size by Players
3.3.4 Others Market Size by Players
3.4 Global Human Microbiome Sequencing Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Human Microbiome Sequencing Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Human Microbiome Sequencing Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Human Microbiome Sequencing Services Market Size by Type (2020-2031)
6.4 North America Human Microbiome Sequencing Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Human Microbiome Sequencing Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Human Microbiome Sequencing Services Market Size by Type (2020-2031)
7.4 Europe Human Microbiome Sequencing Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Human Microbiome Sequencing Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Human Microbiome Sequencing Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Human Microbiome Sequencing Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Human Microbiome Sequencing Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Human Microbiome Sequencing Services Market Size by Type (2020-2031)
9.4 Central and South America Human Microbiome Sequencing Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Human Microbiome Sequencing Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Human Microbiome Sequencing Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Human Microbiome Sequencing Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Human Microbiome Sequencing Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Illumina
11.1.1 Illumina Corporation Information
11.1.2 Illumina Business Overview
11.1.3 Illumina Human Microbiome Sequencing Services Product Features and Attributes
11.1.4 Illumina Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.1.5 Illumina Human Microbiome Sequencing Services Revenue by Product in 2024
11.1.6 Illumina Human Microbiome Sequencing Services Revenue by Application in 2024
11.1.7 Illumina Human Microbiome Sequencing Services Revenue by Geographic Area in 2024
11.1.8 Illumina Human Microbiome Sequencing Services SWOT Analysis
11.1.9 Illumina Recent Developments
11.2 IGATech
11.2.1 IGATech Corporation Information
11.2.2 IGATech Business Overview
11.2.3 IGATech Human Microbiome Sequencing Services Product Features and Attributes
11.2.4 IGATech Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.2.5 IGATech Human Microbiome Sequencing Services Revenue by Product in 2024
11.2.6 IGATech Human Microbiome Sequencing Services Revenue by Application in 2024
11.2.7 IGATech Human Microbiome Sequencing Services Revenue by Geographic Area in 2024
11.2.8 IGATech Human Microbiome Sequencing Services SWOT Analysis
11.2.9 IGATech Recent Developments
11.3 Genetic Analysis
11.3.1 Genetic Analysis Corporation Information
11.3.2 Genetic Analysis Business Overview
11.3.3 Genetic Analysis Human Microbiome Sequencing Services Product Features and Attributes
11.3.4 Genetic Analysis Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.3.5 Genetic Analysis Human Microbiome Sequencing Services Revenue by Product in 2024
11.3.6 Genetic Analysis Human Microbiome Sequencing Services Revenue by Application in 2024
11.3.7 Genetic Analysis Human Microbiome Sequencing Services Revenue by Geographic Area in 2024
11.3.8 Genetic Analysis Human Microbiome Sequencing Services SWOT Analysis
11.3.9 Genetic Analysis Recent Developments
11.4 BaseClear
11.4.1 BaseClear Corporation Information
11.4.2 BaseClear Business Overview
11.4.3 BaseClear Human Microbiome Sequencing Services Product Features and Attributes
11.4.4 BaseClear Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.4.5 BaseClear Human Microbiome Sequencing Services Revenue by Product in 2024
11.4.6 BaseClear Human Microbiome Sequencing Services Revenue by Application in 2024
11.4.7 BaseClear Human Microbiome Sequencing Services Revenue by Geographic Area in 2024
11.4.8 BaseClear Human Microbiome Sequencing Services SWOT Analysis
11.4.9 BaseClear Recent Developments
11.5 Microba Life Sciences
11.5.1 Microba Life Sciences Corporation Information
11.5.2 Microba Life Sciences Business Overview
11.5.3 Microba Life Sciences Human Microbiome Sequencing Services Product Features and Attributes
11.5.4 Microba Life Sciences Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.5.5 Microba Life Sciences Human Microbiome Sequencing Services Revenue by Product in 2024
11.5.6 Microba Life Sciences Human Microbiome Sequencing Services Revenue by Application in 2024
11.5.7 Microba Life Sciences Human Microbiome Sequencing Services Revenue by Geographic Area in 2024
11.5.8 Microba Life Sciences Human Microbiome Sequencing Services SWOT Analysis
11.5.9 Microba Life Sciences Recent Developments
11.6 Viome
11.6.1 Viome Corporation Information
11.6.2 Viome Business Overview
11.6.3 Viome Human Microbiome Sequencing Services Product Features and Attributes
11.6.4 Viome Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.6.5 Viome Recent Developments
11.7 Goodgut
11.7.1 Goodgut Corporation Information
11.7.2 Goodgut Business Overview
11.7.3 Goodgut Human Microbiome Sequencing Services Product Features and Attributes
11.7.4 Goodgut Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.7.5 Goodgut Recent Developments
11.8 Origin Sciences
11.8.1 Origin Sciences Corporation Information
11.8.2 Origin Sciences Business Overview
11.8.3 Origin Sciences Human Microbiome Sequencing Services Product Features and Attributes
11.8.4 Origin Sciences Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.8.5 Origin Sciences Recent Developments
11.9 Ixcela
11.9.1 Ixcela Corporation Information
11.9.2 Ixcela Business Overview
11.9.3 Ixcela Human Microbiome Sequencing Services Product Features and Attributes
11.9.4 Ixcela Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.9.5 Ixcela Recent Developments
11.10 ProDigest
11.10.1 ProDigest Corporation Information
11.10.2 ProDigest Business Overview
11.10.3 ProDigest Human Microbiome Sequencing Services Product Features and Attributes
11.10.4 ProDigest Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Enterome
11.11.1 Enterome Corporation Information
11.11.2 Enterome Business Overview
11.11.3 Enterome Human Microbiome Sequencing Services Product Features and Attributes
11.11.4 Enterome Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.11.5 Enterome Recent Developments
11.12 The BioCollective
11.12.1 The BioCollective Corporation Information
11.12.2 The BioCollective Business Overview
11.12.3 The BioCollective Human Microbiome Sequencing Services Product Features and Attributes
11.12.4 The BioCollective Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.12.5 The BioCollective Recent Developments
11.13 ZOE
11.13.1 ZOE Corporation Information
11.13.2 ZOE Business Overview
11.13.3 ZOE Human Microbiome Sequencing Services Product Features and Attributes
11.13.4 ZOE Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.13.5 ZOE Recent Developments
11.14 Qiagen
11.14.1 Qiagen Corporation Information
11.14.2 Qiagen Business Overview
11.14.3 Qiagen Human Microbiome Sequencing Services Product Features and Attributes
11.14.4 Qiagen Human Microbiome Sequencing Services Revenue and Gross Margin (2020-2025)
11.14.5 Qiagen Recent Developments
12 Human Microbiome Sequencing ServicesIndustry Chain Analysis
12.1 Human Microbiome Sequencing Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Human Microbiome Sequencing Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Human Microbiome Sequencing Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Human Microbiome Sequencing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Human Microbiome Sequencing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Human Microbiome Sequencing Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Human Microbiome Sequencing Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Human Microbiome Sequencing Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Human Microbiome Sequencing Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Human Microbiome Sequencing Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Sequencing Services as of 2024)
Table 11. Global Human Microbiome Sequencing Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Human Microbiome Sequencing Services Companies Headquarters
Table 13. Global Human Microbiome Sequencing Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Human Microbiome Sequencing Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Human Microbiome Sequencing Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Human Microbiome Sequencing Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Human Microbiome Sequencing Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Human Microbiome Sequencing Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Human Microbiome Sequencing Services Growth Accelerators and Market Barriers
Table 25. North America Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Human Microbiome Sequencing Services Growth Accelerators and Market Barriers
Table 27. Europe Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Human Microbiome Sequencing Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Human Microbiome Sequencing Services Investment Opportunities and Key Challenges
Table 31. Central and South America Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Human Microbiome Sequencing Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Human Microbiome Sequencing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Illumina Corporation Information
Table 35. Illumina Description and Major Businesses
Table 36. Illumina Product Features and Attributes
Table 37. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Illumina Revenue Proportion by Product in 2024
Table 39. Illumina Revenue Proportion by Application in 2024
Table 40. Illumina Revenue Proportion by Geographic Area in 2024
Table 41. Illumina Human Microbiome Sequencing Services SWOT Analysis
Table 42. Illumina Recent Developments
Table 43. IGATech Corporation Information
Table 44. IGATech Description and Major Businesses
Table 45. IGATech Product Features and Attributes
Table 46. IGATech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. IGATech Revenue Proportion by Product in 2024
Table 48. IGATech Revenue Proportion by Application in 2024
Table 49. IGATech Revenue Proportion by Geographic Area in 2024
Table 50. IGATech Human Microbiome Sequencing Services SWOT Analysis
Table 51. IGATech Recent Developments
Table 52. Genetic Analysis Corporation Information
Table 53. Genetic Analysis Description and Major Businesses
Table 54. Genetic Analysis Product Features and Attributes
Table 55. Genetic Analysis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Genetic Analysis Revenue Proportion by Product in 2024
Table 57. Genetic Analysis Revenue Proportion by Application in 2024
Table 58. Genetic Analysis Revenue Proportion by Geographic Area in 2024
Table 59. Genetic Analysis Human Microbiome Sequencing Services SWOT Analysis
Table 60. Genetic Analysis Recent Developments
Table 61. BaseClear Corporation Information
Table 62. BaseClear Description and Major Businesses
Table 63. BaseClear Product Features and Attributes
Table 64. BaseClear Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. BaseClear Revenue Proportion by Product in 2024
Table 66. BaseClear Revenue Proportion by Application in 2024
Table 67. BaseClear Revenue Proportion by Geographic Area in 2024
Table 68. BaseClear Human Microbiome Sequencing Services SWOT Analysis
Table 69. BaseClear Recent Developments
Table 70. Microba Life Sciences Corporation Information
Table 71. Microba Life Sciences Description and Major Businesses
Table 72. Microba Life Sciences Product Features and Attributes
Table 73. Microba Life Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Microba Life Sciences Revenue Proportion by Product in 2024
Table 75. Microba Life Sciences Revenue Proportion by Application in 2024
Table 76. Microba Life Sciences Revenue Proportion by Geographic Area in 2024
Table 77. Microba Life Sciences Human Microbiome Sequencing Services SWOT Analysis
Table 78. Microba Life Sciences Recent Developments
Table 79. Viome Corporation Information
Table 80. Viome Description and Major Businesses
Table 81. Viome Product Features and Attributes
Table 82. Viome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Viome Recent Developments
Table 84. Goodgut Corporation Information
Table 85. Goodgut Description and Major Businesses
Table 86. Goodgut Product Features and Attributes
Table 87. Goodgut Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Goodgut Recent Developments
Table 89. Origin Sciences Corporation Information
Table 90. Origin Sciences Description and Major Businesses
Table 91. Origin Sciences Product Features and Attributes
Table 92. Origin Sciences Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Origin Sciences Recent Developments
Table 94. Ixcela Corporation Information
Table 95. Ixcela Description and Major Businesses
Table 96. Ixcela Product Features and Attributes
Table 97. Ixcela Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Ixcela Recent Developments
Table 99. ProDigest Corporation Information
Table 100. ProDigest Description and Major Businesses
Table 101. ProDigest Product Features and Attributes
Table 102. ProDigest Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. ProDigest Recent Developments
Table 104. Enterome Corporation Information
Table 105. Enterome Description and Major Businesses
Table 106. Enterome Product Features and Attributes
Table 107. Enterome Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Enterome Recent Developments
Table 109. The BioCollective Corporation Information
Table 110. The BioCollective Description and Major Businesses
Table 111. The BioCollective Product Features and Attributes
Table 112. The BioCollective Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. The BioCollective Recent Developments
Table 114. ZOE Corporation Information
Table 115. ZOE Description and Major Businesses
Table 116. ZOE Product Features and Attributes
Table 117. ZOE Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. ZOE Recent Developments
Table 119. Qiagen Corporation Information
Table 120. Qiagen Description and Major Businesses
Table 121. Qiagen Product Features and Attributes
Table 122. Qiagen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Qiagen Recent Developments
Table 124. Raw Materials Key Suppliers
Table 125. Distributors List
Table 126. Market Trends and Market Evolution
Table 127. Market Drivers and Opportunities
Table 128. Market Challenges, Risks, and Restraints
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources


List of Figures
Figure 1. Human Microbiome Sequencing Services Product Picture
Figure 2. Global Human Microbiome Sequencing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 16S rRNA Sequencing Product Picture
Figure 4. Shot Gun Metagenomics Product Picture
Figure 5. Metatranscriptomics Product Picture
Figure 6. Others Product Picture
Figure 7. Global Human Microbiome Sequencing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 8. Hospitals
Figure 9. Research Institutes
Figure 10. Pharmaceutical Companies
Figure 11. Human Microbiome Sequencing Services Report Years Considered
Figure 12. Global Human Microbiome Sequencing Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 14. Global Human Microbiome Sequencing Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Human Microbiome Sequencing Services Revenue Market Share by Region (2020-2031)
Figure 16. Global Human Microbiome Sequencing Services Revenue Market Share Ranking (2024)
Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 18. 16S rRNA Sequencing Revenue Market Share by Player in 2024
Figure 19. Shot Gun Metagenomics Revenue Market Share by Player in 2024
Figure 20. Metatranscriptomics Revenue Market Share by Player in 2024
Figure 21. Others Revenue Market Share by Player in 2024
Figure 22. Global Human Microbiome Sequencing Services Revenue Market Share by Type (2020-2031)
Figure 23. Global Human Microbiome Sequencing Services Revenue Market Share by Application (2020-2031)
Figure 24. North America Human Microbiome Sequencing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 25. North America Top 5 Players Human Microbiome Sequencing Services Revenue (US$ Million) in 2024
Figure 26. North America Human Microbiome Sequencing Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 27. North America Human Microbiome Sequencing Services Revenue (US$ Million) by Application (2020-2031)
Figure 28. US Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 29. Canada Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 30. Mexico Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 31. Europe Human Microbiome Sequencing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 32. Europe Top 5 Players Human Microbiome Sequencing Services Revenue (US$ Million) in 2024
Figure 33. Europe Human Microbiome Sequencing Services Revenue (US$ Million) by Type (2020-2031)
Figure 34. Europe Human Microbiome Sequencing Services Revenue (US$ Million) by Application (2020-2031)
Figure 35. Germany Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 36. France Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 37. U.K. Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 38. Italy Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 39. Russia Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 40. Asia-Pacific Human Microbiome Sequencing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Asia-Pacific Top 8 Players Human Microbiome Sequencing Services Revenue (US$ Million) in 2024
Figure 42. Asia-Pacific Human Microbiome Sequencing Services Revenue (US$ Million) by Type (2020-2031)
Figure 43. Asia-Pacific Human Microbiome Sequencing Services Revenue (US$ Million) by Application (2020-2031)
Figure 44. Indonesia Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 45. Japan Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 46. South Korea Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 47. Australia Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 48. India Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 49. Indonesia Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 50. Vietnam Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 51. Malaysia Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 52. Philippines Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 53. Singapore Human Microbiome Sequencing Services Revenue (2020-2031) & (US$ Million)
Figure 54. Central and South America Human Microbiome Sequencing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Central and South America Top 5 Players Human Microbiome Sequencing Services Revenue (US$ Million) in 2024
Figure 56. Central and South America Human Microbiome Sequencing Services Revenue (US$ Million) by Type (2020-2031)
Figure 57. Central and South America Human Microbiome Sequencing Services Revenue (US$ Million) by Application (2020-2031)
Figure 58. Brazil Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 59. Argentina Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 60. Middle East and Africa Human Microbiome Sequencing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 61. Middle East and Africa Top 5 Players Human Microbiome Sequencing Services Revenue (US$ Million) in 2024
Figure 62. South America Human Microbiome Sequencing Services Revenue (US$ Million) by Type (2020-2031)
Figure 63. Middle East and Africa Human Microbiome Sequencing Services Revenue (US$ Million) by Application (2020-2031)
Figure 64. GCC Countries Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 65. Israel Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 66. Egypt Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 67. South Africa Human Microbiome Sequencing Services Revenue (2020-2025) & (US$ Million)
Figure 68. Human Microbiome Sequencing Services Industry Chain Mapping
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies